Master of Science in Cancer Immunotherapy: Advanced Research
Program Description
The MSc in Cancer Immunotherapy with Advanced Research at the University of Hertfordshire is a two-year postgraduate program designed for students aiming to specialize in cutting-edge cancer treatments. The curriculum delves into areas such as adoptive T cell therapy, tumor-associated macrophages, natural killer (NK) cells, monoclonal antibodies, cancer vaccines, microbial therapies, and immune checkpoint blockade. Students engage in a substantial research internship and an extended research project, gaining hands-on experience in advanced laboratory techniques. Graduates are well-prepared for careers in pharmaceutical research, clinical trials, public health, academia, and may pursue further studies like PhDs.
Program Requirements
Language Requirements
| Test | Overall Score | Listening | Reading | Writing | Speaking |
|---|---|---|---|---|---|
| IELTS | 6.5 | 5.5 | 5.5 | 5.5 | 5.5 |
| PTE - A | 59.0 | 59.0 | 59.0 | 59.0 | 59.0 |
| TOEFL | 79.0 | 17.0 | 18.0 | 17.0 | 20.0 |
Academic Scores
| Scale | Minimum Score Required |
|---|---|
| GPA Scale (0-4.00) | 2.60 |
Program Intakes
| September, 2026 |
|---|
| January, 2027 |
| September, 2027 |
Recommended Programs
1 Year
On Campus
January, September
Applied and Pure Science
1 Year
On Campus
January, September
Applied and Pure Science
1 Year
On Campus
January, September
Applied and Pure Science
1 Year
On Campus
January, September
Applied and Pure Science
